To extend our findings in vivo, we treated patient tumour-bearing mice with vehicle, IKKβ inhibitor (BMS345541 100 mg/kg daily), aurora kinase inhibitor (MLN8237 30 mg/kg daily), or both. Here, IKBKB is linked to neoplasm.